BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 32719094)

  • 21. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
    Zhou H; He Y; Li L; Wu C; Hu G
    Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
    Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
    J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
    Yang J; Xie K; Li C
    Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
    Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
    Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
    He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
    Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
    J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
    Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
    BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8
    Zhang Y; Li L; Zheng W; Zhang L; Yao N
    Ann Transl Med; 2022 Mar; 10(6):273. PubMed ID: 35434003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
    Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
    Front Genet; 2022; 13():1085700. PubMed ID: 36579330
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
    Ding Z; Li H; Yu D
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.